Cite
HARVARD Citation
Manns, M. et al. (n.d.). Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial. Lancet infectious diseases. 16 (6), pp. 685-697. [Online].